About Zaklad Diagnostyki Obrazowej
Clinical Trials at Zaklad Diagnostyki Obrazowej
During the past decade, Zaklad Diagnostyki Obrazowej conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Zaklad Diagnostyki Obrazowej
According to Clinical.Site data, the most researched conditions in "Zaklad Diagnostyki Obrazowej" are
"Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "Zaklad Diagnostyki Obrazowej" in a lesser frequency.
Clinical Trials Intervention Types at Zaklad Diagnostyki Obrazowej
Most popular intervention types in "Zaklad Diagnostyki Obrazowej" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "PF-02341066" (2 trials), "Docetaxel" (1 trials) and "Pemetrexed" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Zaklad Diagnostyki Obrazowej
The vast majority of trials in "Zaklad Diagnostyki Obrazowej" are
2 trials for "All" genders.
Clinical Trials Status at Zaklad Diagnostyki Obrazowej
Currently, there are NaN active trials in "Zaklad Diagnostyki Obrazowej".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Zaklad Diagnostyki Obrazowej,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Zaklad Diagnostyki Obrazowej, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".